Department of Urology and Pediatric Urology, Klinikum Fulda, Fulda, Germany.
Eur Urol. 2011 Nov;60(5):1081-6. doi: 10.1016/j.eururo.2011.07.006. Epub 2011 Jul 14.
The risk estimation of secondary tumors after different types of urinary diversion with intestinal segments is possible only for ureterosigmoidostomy owing to the lack of follow-up studies of other forms of urinary diversions.
We calculated the prevalence of secondary tumors associated with different forms of urinary diversion, relating the number of reported tumors to the number of performed diversions in German clinics.
DESIGN, SETTING, AND PARTICIPANTS: We analyzed the operative records of 44 German clinics for urinary diversions performed from 1970 to 2007 and registered all reported secondary tumors up to 2009.
For statistical comparison of the different tumor prevalences, Fisher exact test was used. Additionally, we compared tumor locations and latency periods in different forms of urinary diversions.
In 17,758 urinary diversions, 32 secondary tumors occurred. The tumor risk in ureterosigmoidostomy (2.58%) and cystoplasty (1.58%) was significantly higher than in other continent forms of urinary diversion (p<0.0001). The risk in orthotopic (ileo-)colonic neobladders (1.29%) was significantly higher (p=0.0001) than in ileal neobladders (0.05%). The difference between ileocecal pouches (0.14%) and ileal neobladders was not significant (p=0.46), and the tumor risk with ileal conduits was minimal (0.02%).
Ureterosigmoidostomies, cystoplasties, and probably orthotopic (ileo-)colonic neobladders bear a significantly increased tumor risk compared with the general population and necessitate regular endoscopic evaluation from at least the fifth postoperative year. Regular endoscopy is not imperative after ileal neobladders and conduits, but with catheterizable ileocecal pouches, it is recommended in the presence of symptoms such as hydronephrosis, chronic urinary infection, and hematuria.
由于缺乏对其他类型尿路改道的随访研究,只有输尿管乙状结肠吻合术的二次肿瘤风险评估是可能的。
我们计算了不同类型尿路改道相关的继发性肿瘤的患病率,并将报告的肿瘤数量与德国临床实践中进行的尿路改道数量进行了比较。
设计、地点和参与者:我们分析了 1970 年至 2007 年间德国 44 家泌尿科医院的手术记录,并登记了截至 2009 年所有报告的继发性肿瘤。
为了对不同肿瘤患病率进行统计比较,我们使用了 Fisher 精确检验。此外,我们还比较了不同尿路改道方式的肿瘤位置和潜伏期。
在 17758 例尿路改道中,发生了 32 例继发性肿瘤。输尿管乙状结肠吻合术(2.58%)和膀胱成形术(1.58%)的肿瘤风险明显高于其他continent 尿路改道方式(p<0.0001)。原位(回肠-)结肠新膀胱(1.29%)的风险明显更高(p=0.0001),而回肠新膀胱(0.05%)的风险则较低。回肠-盲肠袋(0.14%)和回肠新膀胱之间的差异无统计学意义(p=0.46),而回肠导管的肿瘤风险则最小(0.02%)。
与一般人群相比,输尿管乙状结肠吻合术、膀胱成形术和可能的原位(回肠-)结肠新膀胱的肿瘤风险显著增加,需要至少在术后第五年进行定期内镜评估。回肠新膀胱和导管不需要定期进行内镜检查,但对于可导管化的回肠-盲肠袋,如果存在肾积水、慢性尿路感染和血尿等症状,则建议进行内镜检查。